AFP and neoplasm: Patients in the high AAR group were more likely to have HBeAg-positivity (p < 0.001), positive HBV-DNA (p < 0.001), larger tumour size (p < 0.001), higher incidence of MVI (p < 0.001), and AFP > 400 ng/mL (p = 0.001) than those in the low AAR group.